2024 Mayo Clinic Urology Review is organized by WJ Weiser and Associates, Inc. and will be held from Feb 05 - 09, 2024 at Hyatt Regency Maui Resort And Spa, Maui, Hawaii, United States of America.

Educatonal Needs:
The diagnosis and management of many urologic diseases have been significantly influenced by recent medical, surgical, and technological advances. One of the greatest challenges for the practicing urologist is to stay current with the numerous dynamic changes in the field of urology. A nationally acclaimed faculty has been assembled to provide this update with presentations on localized and locally advanced prostate cancer, sexual dysfunction and infertility, overactive bladder and urinary incontinence, testicular cancer, multidisciplinary management of bladder cancer, as well as novel surgical treatments of BPH, kidney cancer, pelvic floor prolapse, urinary stone disease, and genitourinary reconstruction.

Prostate cancer is the most common non-cutaneous cancer in men in the US, and the second leading cause of male cancer mortality. Patients and physicians continue to struggle with the optimal management of these patients, including surveillance, radiation, surgery, and focal treatment options. An understanding of the advantages and disadvantages of specific treatments allows optimal counseling of this patient population.

Numerous advances in sexual medicine have occurred over the past decade. Post-graduate surgeons have few opportunities to learn new surgical techniques and appreciate the outcomes of their current management strategies in the broader population. The program will therefore provide an update on advances in Peyronie’s disease evaluation and treatment, review options for male and female sexual dysfunction, and understand current treatment approach to male hypogonadism.

While renal preservation using partial nephrectomy is now is the treatment of choice for small lesions, the optimal management of large renal masses is not clear. Elective partial nephrectomy will preserve renal function but at the potential cost of increased risk of tumor recurrence. Moreover, as the use of percutaneous ablation has been increasingly utilized, it is important to understand the risks as well as the clinical utility in terms of influencing treatment. Likewise, there has been increased application of minimally invasive, specifically robotic, surgery for kidney cancer, which introduces questions regarding the techniques of these procedures as well as the best way to manage (and avoid) complications during minimally-invasive renal surgery.

Bladder cancer is the second most common genitourinary cancer in males and the fourth most common in females. While intravesical therapy is a recommended approach for patients with high-risk non-muscle invasive tumors, the optimal management for patients with recurrent high grade non-muscle invasive disease continues to be debated. Meanwhile, muscle invasive cancer accounts often presents de novo with the first manifestation of the disease. Practitioners need to be aware of the options for managing muscle invasive bladder cancer with a focus on the proper selection of patients for the various treatment modalities.

It has become increasingly difficult for the practicing urologist to stay abreast with the many dynamic changes in the treatment of BPH. Moreover, given the prevalence of BPH in the aging male population, practitioners need to be aware of the more complex situations that will be encountered which may affect BPH management, including bladder stones and poor baseline bladder function. Meanwhile, urinary incontinence and overactive bladder remain among the most common diagnoses seen by urologists, and the continued expansion of medical and surgical options warrants updated review.

There has been continued expansion in the technology available for the endoscopic management of ureteral and renal urolithiasis, while increasing scrutiny on the impact of what are often repeated procedures on patient morbidity and health system costs mandate a detailed review of technology and available options for medical and surgical management of recurrent stone disease.

Lastly, the field of genitourinary reconstruction has greatly expanded to address both pediatric and adult conditions. Cancer survivorship, neurourology, and urinary trauma and stricture disease are increasingly identified areas of need to improve patient quality of life and reduce health care cost. A broad understanding of these topics is essential to provide effective urologic care.

Educational Objectives:
At the conclusion of the 2024 Mayo Clinic Urology Review, attendees will be able to:
• Describe and recognize the utility of currently available biomarker panels for risk stratification of patients with newly diagnosed prostate cancer.
• Evaluate recent advances in imaging for, as well as local and systemic therapy of, advanced prostate carcinoma.
• Identify the roles of androgen deprivation therapy and treatment options for biochemical recurrence after radical prostatectomy.
• Recognize treatment outcomes after radiation for patients with prostate cancer.
• Discuss treatment options for female sexual dysfunction.
• Describe latest updates on evaluation and management of erectile dysfunction
• Recognize the various management strategies for Peyronie’s disease and determine the factors which should be incorporated to individualize treatment approach.
• Recognize the surgical nuances of pelvic organ prolapse.
• Describe the pros and cons of renal mass biopsy and management of small renal masses.
• Assess the risks and benefits of partial nephrectomy and ablation for renal masses.
• Apply the techniques involved with minimally invasive renal surgery, including partial nephrectomy and nephroureterectomy, and be able to manage complications related to robotic renal surgery
• Recognize the role of cytoreductive nephrectomy for kidney cancer
• Evaluate the outcomes following targeted therapy and immunotherapy for patients with advanced renal cell carcinoma
• Create strategies for the surgical management of renal and ureteral stones.
• Recognize the options for the metabolic evaluation and medical management of patients with urolithiasis.
• Describe BCG-refractory disease and recognize the options for management available for these patients.
• Review the evidence supporting peri-operative chemotherapy as part of a multimodality treatment for invasive urothelial carcinoma.
• Identify options for managing (and avoiding) perioperative complications with radical cystectomy
• Recognize the various surgical options for BPH, and be able to identify appropriate patients for minimally-invasive therapies of BPH.
• Create strategies for the management of male urinary incontinence.
• Review the diagnosis and management of anterior vaginal wall lesions.
• Discuss the causes and optimal management of sacral neuromodulation.
• Describe management and treatment options for recurrent urinary tract infections and prostatitis.
• Review standard care for the more common pediatric urologic emergencies.
• Review surgical principles in the management of patients with testicular cancer.
• Discuss the latest updates on COVID-19, vaccines, boosters, and variants.
• Review urologic work-up and follow-up for neurogenic bladder.
• Identify common dermatologic findings in the genitourinary exam.
• Discuss management of urinary stricture disease.
• Review the principles of urologic trauma management.
• Discuss medical-legal aspects of medicine.
• Identify the emerging role of professional development and effective communication in urology.
• Review updates on coding and billing in urology.